🇺🇸 FDA
Patent

US 8933201

Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use

granted A61KA61K38/00A61P

Quick answer

US patent 8933201 (Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K38/00, A61P, A61P35/00, A61P9/10